Pseudoneutralizing test for preclinical studies of vaccines against SARS-CoV-2

Pseudoneutralizing test for preclinical studies of vaccines against SARS-CoV-2

The purpose of this study was to evaluate efficiency of a competitive enzyme immunoassay which specifically detects antibodies that recognize the receptor-binding domain at the S1 subunit of SARS-CoV-2 coronavirus spike protein and block the formation of initiator infection complex between RBD and a...

Full description

Saved in:
Bibliographic Details
Main Authors: B. S. Cherepovich, A. M. Kudryashova, N. P. Kartashova, A. V. Gracheva, V. A. Manuilov, I. A. Leneva, O. V. Borisova, O. A. Svitich
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2024-04-01
Series:Медицинская иммунология
Subjects:
covid-19
sars-cov-2
solid-phase elisa
virus-neutralizing antibodies
pseudo-neutralizing test
blood serum
animals
Online Access:https://www.mimmun.ru/mimmun/article/view/2905
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mimmun.ru/mimmun/article/view/2905

Similar Items